Sharon Blank

In a technologically advanced health care landscape, solutions to address language barriers are necessary and can be the difference between life and death for complex medication regimens.

In part 2, Blank argues that the language on a medication’s label deserves the same regulatory scrutiny given to the drugs themselves and how they affect patients.

Sharon Blank, CEO of RxTran and Language Scientific, discusses language hurdles in the safe delivery of medications for patients and pharmacists alike.